This website is intended for Australian patients prescribed Lagevrio® (molnupiravir) and their carers.
PRESCRIPTION ONLY MEDICINE
KEEP OUT OF REACH OF CHILDREN
Each capsule contains 200 mg molnupiravir
Each bottle contains 40 capsules
AUST R 372650
Store below 30ºC
If you have any questions about your condition or the medicine you have been prescribed, please talk to your doctor or pharmacist.
Have a question about an MSD Product or want to report an Adverse Event or Quality Issue?
Phone: 1800 818 553
Monday – Friday 9:30 a.m. – 5:30 p.m. AEDT
MSD Australia Head Office
Phone: +61 2 8988 8000
Monday – Friday 8:30 a.m. – 5:30 p.m. AEDT
Level 1, 26 Talavera Road
Macquarie Park, NSW 2113
LAGEVRIO® will be provided to the Australian Government and distributed via the National Medical Stockpile in accordance with the supply agreement. The Australian Government will determine access to LAGEVRIO for eligible patients.
Copyright © 2022 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. All rights reserved.
AU-ANV-00014 First issued January 2022.